News AbbVie signs $225m 'immunoneurology' deal to tackle Alzheime... Partnership will use novel approach to treating Alzheimer's.
News Rezzayo antifungal okayed as Candida auris rings alarm bells Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
